Authors:
CHEN WQ
KOENIGS LL
THOMPSON SJ
PETER RM
PETTIE AE
TRAGER WF
NELSON SD
Citation: Wq. Chen et al., OXIDATION OF ACETAMINOPHEN TO ITS TOXIC QUINONE IMINE AND NONTOXIC CATECHOL METABOLITES BY BACULOVIRUS-EXPRESSED AND PURIFIED HUMAN CYTOCHROMES P450 2E1 AND 2A6, Chemical research in toxicology, 11(4), 1998, pp. 295-301
Citation: Jf. Darbyshire et al., SELECTIVELY DEUTERATED WARFARIN - SUBSTRATE PROBE FOR THE MECHANISM OF AROMATIC HYDROXYLATION CATALYZED BY CYTOCHROME-P450, The FASEB journal, 12(5), 1998, pp. 5567-5567
Authors:
KHOJASTEHBAKHT SC
KOENIGS LL
PETER RM
TRAGER WF
NELSON SD
Citation: Sc. Khojastehbakht et al., (R)-(-MENTHOFURAN IS A POTENT, MECHANISM-BASED INACTIVATOR OF HUMAN LIVER CYTOCHROME-P450 2A6()), Drug metabolism and disposition, 26(7), 1998, pp. 701-704
Citation: Ll. Koenigs et Wf. Trager, MECHANISM-BASED INACTIVATION OF CYTOCHROME-P450 2B1 BY 8-METHOXYPSORALEN AND SEVERAL OTHER FURANOCOUMARINS, Biochemistry, 37(38), 1998, pp. 13184-13193
Authors:
STEWARD DJ
HAINING RL
HENNE KR
DAVIS G
RUSHMORE TH
TRAGER WF
RETTIE AE
Citation: Dj. Steward et al., GENETIC ASSOCIATION BETWEEN SENSITIVITY TO WARFARIN AND EXPRESSION OFCYP2C9-ASTERISK-3, Pharmacogenetics, 7(5), 1997, pp. 361-367
Citation: Ll. Koenigs et al., ISOFORM-SELECTIVE MECHANISM-BASED INACTIVATION OF HUMAN P450 2A6 BY 8-METHOXYPSORALEN (8-MOP), The FASEB journal, 11(9), 1997, pp. 185-185
Authors:
MORGANROTH J
LYNESS WH
PERHACH JL
MATHER GG
HARR JE
TRAGER WF
LEVY RH
ROSENBERG A
Citation: J. Morganroth et al., LACK OF EFFECT OF AZELASTINE AND KETOCONAZOLE COADMINISTRATION ON ELECTROCARDIOGRAPHIC PARAMETERS IN HEALTHY-VOLUNTEERS, Journal of clinical pharmacology, 37(11), 1997, pp. 1065-1072
Citation: Ll. Koenigs et al., MECHANISM-BASED INACTIVATION OF HUMAN LIVER CYTOCHROME-P450 2A6 BY 8-METHOXYPSORALEN, Drug metabolism and disposition, 25(12), 1997, pp. 1407-1415
Authors:
TRAN A
REY E
PONS G
ROUSSEAU M
DATHIS P
OLIVE G
MATHER GG
BISHOP FE
WURDEN CJ
LABROO R
TRAGER WF
KUNZE KL
THUMMEL KE
VINCENT JC
GILLARDIN JM
LEPAGE F
LEVY RH
Citation: A. Tran et al., INFLUENCE OF STIRIPENTOL ON CYTOCHROME P450-MEDIATED METABOLIC PATHWAYS IN HUMANS - IN-VITRO AND IN-VIVO COMPARISON AND CALCULATION OF IN-VIVO INHIBITION CONSTANTS, Clinical pharmacology and therapeutics, 62(5), 1997, pp. 490-504
Authors:
MATHER GG
HARR JH
HARGREAVES JA
TRAGER WF
LEVY RH
Citation: Gg. Mather et al., LACK OF HUMAN CYP450 INHIBITION BY TIZANIDINE AND 2 MAJOR METABOLITES, Clinical pharmacology and therapeutics, 61(2), 1997, pp. 9-9
Citation: Kr. Iyer et al., INTRAMOLECULAR ISOTOPE EFFECTS FOR BENZYLIC HYDROXYLATION OF ISOMERICXYLENES AND 4,4'-DIMETHYLBIPHENYL BY CYTOCHROME-P450 - RELATIONSHIP BETWEEN DISTANCE OF METHYL-GROUPS AND MASKING OF THE INTRINSIC ISOTOPE EFFECT, Biochemistry, 36(23), 1997, pp. 7136-7143
Citation: Jf. Darbyshire et al., SELECTIVELY DEUTERATED WARFARIN - SUBSTRATE PROBE FOR THE MECHANISM OF AROMATIC HYDROXYLATION CATALYZED BY CYTOCHROME-P450, Drug metabolism and disposition, 24(9), 1996, pp. 1038-1045
Authors:
WIENKERS LC
WURDEN CJ
STORCH E
KUNZE KL
RETTIE AE
TRAGER WF
Citation: Lc. Wienkers et al., FORMATION OF (R)-8-HYDROXYWARFARIN IN HUMAN LIVER-MICROSOMES - A NEW METABOLIC MARKER FOR THE (S)-MEPHENYTOIN HYDROXYLASE, P4502C19, Drug metabolism and disposition, 24(5), 1996, pp. 610-614
Authors:
KUNZE KL
WIENKERS LC
THUMMEL KE
TRAGER WF
Citation: Kl. Kunze et al., WARFARIN-FLUCONAZOLE .1. INHIBITION OF THE HUMAN CYTOCHROME-P450-DEPENDENT METABOLISM OF WARFARIN BY FLUCONAZOLE - IN-VITRO STUDIES, Drug metabolism and disposition, 24(4), 1996, pp. 414-421
Authors:
BLACK DJ
KUNZE KL
WIENKERS LC
GIDAL BE
SEATON TL
MCDONNELL ND
EVANS JS
BAUWENS E
TRAGER WF
Citation: Dj. Black et al., WARFARIN-FLUCONAZOLE .2. A METABOLICALLY BASED DRUG-INTERACTION - IN-VIVO STUDIES, Drug metabolism and disposition, 24(4), 1996, pp. 422-428
Citation: Kl. Kunze et Wf. Trager, WARFARIN-FLUCONAZOLE .2. A RATIONAL APPROACH TO MANAGEMENT OF A METABOLICALLY BASED DRUG-INTERACTION, Drug metabolism and disposition, 24(4), 1996, pp. 429-435
Citation: Jp. Jones et al., 3-DIMENSIONAL QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP FOR INHIBITORS OF CYTOCHROME P4502C9, Drug metabolism and disposition, 24(1), 1996, pp. 1-6
Authors:
HAINING RL
HUNTER AP
VERONESE ME
TRAGER WF
RETTIE AE
Citation: Rl. Haining et al., ALLELIC VARIANTS OF HUMAN CYTOCHROME-P450 2C9 - BACULOVIRUS-MEDIATED EXPRESSION, PURIFICATION, STRUCTURAL CHARACTERIZATION, SUBSTRATE STEREOSELECTIVITY, AND PROCHIRAL SELECTIVITY OF THE WILD-TYPE AND I359L MUTANT FORMS, Archives of biochemistry and biophysics, 333(2), 1996, pp. 447-458
Authors:
CARLSON TJ
JONES JP
PETERSON L
CASTAGNOLI N
IYER KR
TRAGER WF
Citation: Tj. Carlson et al., STEREOSELECTIVITY AND ISOTOPE EFFECTS ASSOCIATED WITH CYTOCHROME P450-CATALYZED OXIDATION OF (S)-NICOTINE - THE POSSIBILITY OF INITIAL HYDROGEN ATOM ABSTRACTION IN THE FORMATION OF THE DELTA-1',5'-NICOTINIUM ION, Drug metabolism and disposition, 23(7), 1995, pp. 749-756
Citation: Mx. He et al., INHIBITION OF (S)-WARFARIN METABOLISM BY SULFINPYRAZONE AND ITS METABOLITES, Drug metabolism and disposition, 23(6), 1995, pp. 659-663
Authors:
LABROO RB
THUMMEL KE
KUNZE KL
PODOLL T
TRAGER WF
KHARASCH ED
Citation: Rb. Labroo et al., CATALYTIC ROLE OF CYTOCHROME P4503A4 IN MULTIPLE PATHWAYS OF ALFENTANIL METABOLISM, Drug metabolism and disposition, 23(4), 1995, pp. 490-496